Table 2.

Effect of the crude extract and fraction 12 on hematological parameters.

PH treatments	Doses (mg/kg)	WBC (×109/l)	RBC (×1012/l)	PL (%)	MPV (fl)	PDW	HGB (g/dl)	HCT (%)	MCV (fl)	MCHC (Pg)	MCHC (g/dl)	DIRBC (%)
Neutral control	0	7.6 ± 1.1∗	9.10 ± 0.5∗	0.45 ± 0.05	6.60 ± 0.20	14.20 ± 0.10	14.3 ± 1.60∗	48.3 ± 0.8∗	54.22 ± 3.40	15.70 ± 0.70	31.10 ± 0.20	17.70 ± 0.50
Negative control		14.10 ± 2.10	6.80 ± 0.40	0.32 ± 0.07	6.90 ± 0.20	14.50 ± 0.20	8.70 ± 1.20	32.2 ± 6.50	53.30 ± 3.20	14.80 ± 0.40	29.10 ± 1.20	18.10 ± 0.10
CQ	5	9.10 ± 0.60∗	8.20 ± 0.43∗	0.39 ± 0.06	6.70 ± 0.10	14.10 ± 0.20	10.60 ± 1.20∗	44.10 ± 0.40∗	54.10 ± 2.40	15.00 ± 0.40	31.40 ± 0.30	17.90 ± 0.20
Crude extract	125	10.5 ± 1.03∗	8.30 ± 0.23∗	0.37 ± 0.03	7.00 ± 0.10	14.3 ± 0.20	12.10 ± 0.20∗	41.2 ± 0.9∗	52.11 ± 0.50	14.70 ± 0.60	29.00 ± 0.20	17.70 ± 0.41
	250	11.4 ± 0.20∗	8.68 ± 0.22∗	0.50 ± 0.13	6.90 ± 0.20	14.90 ± 0.30	11.60 ± 0.3∗	40.11 ± 2.1∗	52.00 ± 0.30	13.90 ± 0.90	27.23 ± 0.37	17.60 ± 0.40
	500	10.40 ± 0.23∗	8.70 ± 0.40∗	0.31 ± 0.05	7.00 ± 0.20	14.60 ± 0.20	13.40 ± 0.40∗	42.7 ± 5.40∗	52.20 ± 0.70	14.90 ± 0.50	28.80 ± 0.23	17.20 ± 0.22
Fraction 12	62.5	11.12 ± 0.41∗	8.05 ± 0.06∗	0.39 ± 0.32	6.96 ± 0.06	14.18 ± 0.32	9.36 ± 0.15∗	42.61 ± 0.31∗	53.89 ± 0.12	13.64 ± 0.62	29.06 ± 0.08	17.83 ± 0.14
	125	10.32 ± 0.11∗	8.21 ± 0.07∗	0.43 ± 0.28	6.53 ± 0.02	14.13 ± 0.14	9.86 ± 0.31∗	43.13 ± 0.75∗	54.17 ± 0.58	14.93 ± 0.13	30.02 ± 0.31	17.94 ± 0.74

HCT: hematocrit; HGB: hemoglobin; MCHC: mean corpuscular hemoglobin concentration; MCV: mean corpuscular volume; PL: platelets; DIRBC: distribution index of red blood cells; MPV: mean platelet volume.